Correlation Between Apellis Pharmaceuticals and Mirati Ther
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Mirati Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Mirati Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Mirati Ther, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Mirati Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Mirati Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Mirati Ther.
Diversification Opportunities for Apellis Pharmaceuticals and Mirati Ther
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Apellis and Mirati is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Mirati Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mirati Ther and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Mirati Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mirati Ther has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Mirati Ther go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Mirati Ther
If you would invest 2,734 in Apellis Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 457.00 from holding Apellis Pharmaceuticals or generate 16.72% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 4.76% |
Values | Daily Returns |
Apellis Pharmaceuticals vs. Mirati Ther
Performance |
Timeline |
Apellis Pharmaceuticals |
Mirati Ther |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Apellis Pharmaceuticals and Mirati Ther Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Apellis Pharmaceuticals and Mirati Ther
The main advantage of trading using opposite Apellis Pharmaceuticals and Mirati Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Mirati Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mirati Ther will offset losses from the drop in Mirati Ther's long position.Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
Mirati Ther vs. Sarepta Therapeutics | Mirati Ther vs. Krystal Biotech | Mirati Ther vs. Day One Biopharmaceuticals | Mirati Ther vs. Amylyx Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Fundamental Analysis View fundamental data based on most recent published financial statements |